0001415889-24-005065.txt : 20240223
0001415889-24-005065.hdr.sgml : 20240223
20240223170023
ACCESSION NUMBER: 0001415889-24-005065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SALEKI-GERHARDT AZITA
CENTRAL INDEX KEY: 0001563545
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 24672329
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
form4-02232024_050201.xml
X0508
4
2024-02-21
0001551152
AbbVie Inc.
ABBV
0001563545
SALEKI-GERHARDT AZITA
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
false
true
false
false
EVP, CHIEF OPERATIONS OFFICER
0
Common Stock, $0.01 par value
2024-02-21
4
M
0
52870
58.88
A
296814
D
Common Stock, $0.01 par value
2024-02-21
4
S
0
52870
173.71
D
243944
D
Common Stock, $0.01 par value
2322
I
Profit sharing trust
Common Stock, $0.01 par value
3873
I
By spouse
Option (Right to Buy)
58.88
2024-02-21
4
M
0
52870
58.88
D
2016-02-19
2025-02-18
Common Stock
52870
0
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.51 to $174.03, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Balance in AbbVie Savings program as of January 31, 2024.
The reporting person disclaims beneficial ownership of all securities held by her spouse.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
T.O. Odutayo, attorney-in-fact for Azita Saleki-Gerhardt
2024-02-23